Skip to main navigation Skip to search Skip to main content

Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia

  • H. W. Moon
  • , S. Shin
  • , H. Y. Kim
  • , Y. R. Kim
  • , H. I. Cho
  • , S. S. Yoon
  • , S. Park
  • , B. K. Kim
  • , H. Chun
  • , H. C. Kim
  • , C. J. Park
  • , Y. H. Min
  • , D. Soon Lee*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience